Debt-to-equity of CANNAPHARMARX, INC. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CANNAPHARMARX, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • CANNAPHARMARX, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -153%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CANNAPHARMARX, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -153% 30 Sep 2025
Q2 2025 -157% 30 Jun 2025
Q1 2024 -144% +141% +50% 31 Mar 2024
Q4 2023 -139% +176% +56% 31 Dec 2023
Q3 2023 -234% -104% -80% 30 Sep 2023
Q2 2023 -256% -117% -84% 30 Jun 2023
Q1 2023 -285% -130% -84% 31 Mar 2023
Q4 2022 -315% -138% -78% 31 Dec 2022
Q3 2022 -130% +88% +40% 30 Sep 2022
Q2 2022 -139% +169% +55% 30 Jun 2022
Q1 2022 -155% +381% +71% 31 Mar 2022
Q4 2021 -176% +1596% +90% 31 Dec 2021
Q3 2021 -218% -714% -144% 30 Sep 2021
Q2 2021 -308% -523% -243% 30 Jun 2021
Q1 2021 -536% -675% -487% 31 Mar 2021
Q4 2020 -1772% -1867% -1982% 31 Dec 2020
Q3 2020 496% +390% +371% 30 Sep 2020
Q2 2020 215% +81% +60% 30 Jun 2020
Q1 2020 139% -85% -38% 31 Mar 2020
Q4 2019 94% +515% 31 Dec 2019
Q3 2019 105% +225% 30 Sep 2019
Q2 2019 135% +235% 30 Jun 2019
Q1 2019 224% +324% 31 Mar 2019
Q4 2018 -421% -321% -321% 31 Dec 2018
Q3 2018 -119% -19% -19% 30 Sep 2018
Q2 2018 -101% -0.42% -0.42% 30 Jun 2018
Q1 2018 -100% +0.36% +0.36% 31 Mar 2018
Q4 2017 -100% +0.94% +0.93% 31 Dec 2017
Q3 2017 -100% +1.3% +1.3% 30 Sep 2017
Q2 2017 -100% +14% +12% 30 Jun 2017
Q1 2017 -100% +110% +52% 31 Mar 2017
Q4 2016 -101% +291% +74% 31 Dec 2016
Q3 2016 -101% +752% +88% 30 Sep 2016
Q2 2016 -114% 30 Jun 2016
Q1 2016 -210% 31 Mar 2016
Q4 2015 -392% 31 Dec 2015
Q3 2015 -853% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.